Print Page  |  Close Window
Corporate Profile

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

News Releases
More »

DateTitle 
04/12/17Charles River Laboratories Schedules First-Quarter 2017 Earnings Release and Conference CallPrinter Friendly Version
04/05/17Nimbus Therapeutics Enters into Strategic Partnership with Charles River Laboratories to Advance New Therapeutic ProgramsPrinter Friendly Version
04/03/17Charles River Laboratories Announces Launch of Triple-Immunodeficient Mouse Model for Oncology ResearchPrinter Friendly Version
03/13/17Charles River Laboratories and Chiesi Farmaceutici SpA Announce Extension of Integrated Respiratory Drug Discovery ProgramPrinter Friendly Version
Upcoming Events
More »

DateTitle
05/10/17
8:30 a.m. ET
Q1 2017 Charles River Laboratories International, Inc. Earnings Conference Call

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
Minimum 20 minutes delayed